How depigmenting peel courses approach melasma and persistent pigmentation, including home care, sun protection and treatment limits.
Treatment
The most reliable low-risk texture treatment, and the one most often undermined by home devices.
Read
Treatment
Microneedling with heat added. More remodelling, more downtime, considerably more operator dependency.
Read
Treatment
Controlled injury with a century of clinical history. Depth and skin type decide everything.
Read
Treatment
The most powerful resurfacing available, and the least forgiving of a careless assessment.
Read
Treatment
Four different conditions wearing one word. Getting the diagnosis wrong here is expensive and sometimes permanent.
Read
Treatment
Two problems, in strict order. Active acne is a medical condition; scarring is a staged programme.
Read
Treatment
A medical condition first and a cosmetic one second. The order matters more here than anywhere.
Read
Treatment
Hydration delivered into the skin rather than onto it. Useful where resurfacing is risky.
Read
Treatment
A newer category with genuine promise and marketing that has already outrun the evidence.
Read
Treatment
Prepared from your own blood in the same appointment. The variability between clinics is the whole story.
Read
Treatment
The best version of an event treatment. Real, immediate, and temporary by design.
Read
Depigmenting peels for melasma and persistent pigmentation are usually planned as a course because pigment activity continues between appointments and responds slowly. The in-clinic procedure is only one stage. Consistent prescribed home care, reduced ultraviolet and visible-light exposure, and review of irritation are central to whether improvement is achieved and retained.
Melasma and long-standing patches of pigmentation are not simply surface marks that can reliably be removed in one appointment. Melanin production is influenced by ultraviolet radiation, visible light, heat, inflammation and, for some people, hormonal factors. A peel may speed shedding of pigmented surface cells and form part of a plan to reduce pigment production, but it does not remove every driver that can reactivate colour.
A course gives the clinician time to assess how the skin responds before deciding whether to continue, pause, alter the intensity or focus on barrier recovery. This matters particularly in skin that is prone to post-inflammatory hyperpigmentation, where excess redness, irritation or over-treatment can itself leave darker marks. The intended pace is therefore usually measured and responsive rather than aggressive.
Appointments are also only one component of the intervention. Many depigmenting systems are designed around preparation before an in-clinic application and a structured period of home treatment afterwards. The home phase may be longer than the time spent in the treatment room. A person considering a course should ask which stages are essential, how long each stage is expected to last, what would require a pause, and what maintenance may be needed once the initial programme ends. For example, mesglolondon.co.uk’s pages on a Cosmelan depigmenting peel in Marylebone set out the protocol’s at-home phase and sun avoidance.
Course-based care does not guarantee complete clearance. Melasma can recur, fluctuate with seasons and hormones, or improve unevenly. A useful aim is reduction and better control of visible pigment while protecting the skin from avoidable inflammation and light exposure.
A proper assessment starts with establishing what the discolouration is. Melasma often appears as symmetrical brown or grey-brown patches on the cheeks, forehead, upper lip or jaw, but not every dark patch is melasma. Freckles, sun-related spots, marks after acne or eczema, medication-related pigmentation and some skin lesions need different decisions. New, changing, raised, bleeding or irregularly coloured lesions should be assessed medically rather than treated as cosmetic pigmentation.
The consultation should cover skin type, sensitivity, history of eczema or dermatitis, previous reactions to acids or retinoids, current routine, recent procedures, tendency to cold sores where relevant, and medicines or health circumstances that may affect suitability. Pregnancy and breastfeeding, active irritation, broken skin and recent tanning can change what is appropriate. A clinician may advise delaying treatment rather than proceeding on a fixed timetable.
Preparation can involve simplifying a routine and introducing selected topical products gradually. The purpose is not to make skin peel heavily before treatment. It is to establish tolerance, reduce avoidable irritation and ensure the person can follow the later home instructions. Strong exfoliants, scrubs, waxing, hair-removal products and unapproved active ingredients may need to be stopped around treatment, according to individual advice.
At the appointment, the clinician should explain the anticipated sensations, visible changes and warning signs. Temporary tightness, flaking or redness can occur with peeling treatments. Severe burning, marked swelling, blistering, weeping skin or escalating pain need prompt clinical advice rather than an attempt to treat the reaction with additional actives at home.
The at-home phase commonly asks for consistent use of the products selected for the protocol, gentle cleansing, moisturising where advised and avoidance of products that increase irritation. Depending on the plan, topical pigment-regulating ingredients may be used for a defined period. The exact products, frequency and duration should come from the treating clinician because combining several active products without supervision can damage the skin barrier and complicate the course.
Adherence matters because pigment does not stop changing when an appointment ends. Home treatment is intended to support the effect of the in-clinic stage and reduce the conditions that encourage renewed pigment production. Skipping applications repeatedly, adding unplanned exfoliating acids or retinoids, or stopping protective steps when the skin appears clearer can all make the result harder to judge.
The practical burden should be discussed before starting. Ask whether products need to be applied at fixed times, whether make-up can be worn, what to do if the skin stings, and whether work, travel, exercise or social events need to be adjusted. A written plan is useful because instructions can be difficult to remember once flaking or sensitivity begins.
Do not assume that more product, more frequent use or a stronger product will work faster. In pigment-prone skin, irritation may lead to inflammation and darker marks. If discomfort is persistent or the skin becomes notably red, itchy, cracked or swollen, the safer step is to contact the clinician who set the plan. The course may need modification rather than persistence through a reaction.
For melasma, controlling light exposure is as important as the peel itself. Ultraviolet radiation can stimulate pigment production, and visible light can be relevant for many people with melasma. This is why a plan based only on appointments, without clear advice on exposure, is incomplete. The objective is not to remain indoors indefinitely, but to reduce unnecessary exposure and use the protective measures advised for daily life.
Broad-spectrum sunscreen is commonly recommended as part of pigmentation management. Reapplication, adequate application and protective clothing become especially relevant during prolonged outdoor time. A brimmed hat, shade and planning around high-exposure activities can reduce the amount of light reaching the face. Tinted products containing iron oxides may be discussed for visible-light protection, but suitability and shade should be considered individually.
Freshly treated skin may be more reactive. Direct sun, tanning beds and deliberate tanning can undermine a course and raise the chance of uneven colour changes. Heat may also aggravate melasma for some people, so it is reasonable to ask about hot holidays, outdoor work, exercise conditions and sauna use before booking a programme.
Light protection is not only a short aftercare task. Melasma has a tendency to return, which means protective habits often continue after the active course has finished. A person who cannot realistically follow them during the planned period may be better served by postponing treatment. That is not a failure of commitment: it is a recognition that timing affects safety and the likelihood of a useful result.
The decision to proceed should combine diagnosis, skin condition and practical ability to follow the protocol. It should not be based only on the appearance of a single photograph or on the desire for a rapid result. The table below is a practical rule to take to a consultation. It is not a diagnosis and does not replace an individual assessment.
| Situation | Practical decision rule | Reason to discuss |
|---|---|---|
| Patch has not been diagnosed or has changed | Seek medical assessment before a cosmetic peel. | Not all pigmentation has the same cause or should be treated with a peel. |
| Skin is actively sore, inflamed, broken or sunburnt | Pause and restore skin comfort before considering treatment. | Inflammation can increase the risk of an uneven pigment response. |
| Outdoor holiday, tanning or prolonged exposure is imminent | Consider delaying until exposure can be managed consistently. | Light exposure can reactivate pigmentation during a vulnerable period. |
| Home products cannot be used as directed | Ask whether a different plan or timing is more realistic. | The home phase is part of the course, not a separate add-on. |
| Stinging, swelling or pronounced redness develops | Stop unapproved active products and contact the treating clinician. | The plan may need adjustment to avoid barrier damage. |
| Colour is improving but returns seasonally | Discuss maintenance and ongoing light protection at review. | Melasma often needs long-term management rather than a one-off solution. |
Photographs taken in similar lighting at agreed intervals can help identify gradual change. They are more useful than judging day-to-day in different mirrors or lighting conditions. Review appointments should also consider comfort, not just colour: a calmer skin barrier can be an important sign that a plan is sustainable.
Before agreeing to a course, ask what diagnosis is being treated and why a peel is being proposed rather than another approach. Ask what change is realistic, how long assessment of response may take, and whether the aim is clearing, fading or control. The answer should acknowledge uncertainty, particularly with melasma, instead of implying a permanent result.
Ask for a clear description of the home phase. This should include when to start, what to use, what not to combine, how to manage dryness and who to contact if a reaction develops. It is also sensible to ask whether any current prescription or over-the-counter skincare needs to be reviewed. Bring a list rather than relying on memory.
Follow-up is important because pigmentation treatment should respond to what the skin is doing. Ask when progress will be reviewed, whether photographs will be used, what would count as a reason to pause, and what maintenance looks like if the initial course helps. A plan that cannot be adjusted for irritation or changing circumstances is less suitable for a condition that fluctuates.
Finally, consider the seasonal and practical context. If high sun exposure, travel, outdoor work or a major event makes close adherence unlikely, postponement may be the sensible choice. A treatment course is not defined by the day of the peel. It is defined by the full period of preparation, home care, light protection and review.
This guide explains why depigmenting peel programmes are commonly structured over weeks. It does not diagnose melasma, prescribe products, set a treatment interval or determine whether any particular peel is suitable. Individual protocols differ according to the cause and depth of pigmentation, skin tone, sensitivity, relevant health information and the clinician's assessment.
It does not apply to every mark that looks brown. A new or changing mole, a lesion that bleeds or crusts, a rapidly spreading rash, or a patch with uncertain cause requires appropriate medical assessment. It also does not replace advice from a clinician for people with active skin disease, a history of significant allergic reactions, current medical treatment affecting the skin, or pregnancy and breastfeeding considerations.
Sun avoidance in this context means reducing unnecessary direct exposure and following individual protection advice. It does not mean that everyone needs identical products, clothing or restrictions. People whose work or caring responsibilities keep them outdoors may need a plan that is designed around those realities, or may decide that a different time is safer.
No article can predict an individual result. Pigment can fade slowly, respond unevenly or recur after improvement. The value of a course is in a cautious, reviewable approach that treats the in-clinic peel, the home phase and exposure management as connected parts of one plan.
Disclosure. This article names a business and links to its website. This publication and that website are managed by the same group, which is a commercial relationship. The business did not write or approve the article, and it is named because it is relevant to the subject.
Pigmentation can be driven by ongoing light exposure, inflammation and, in melasma, hormonal influences. A course allows response and irritation to be reviewed over time. It also recognises that the in-clinic peel is only one part of management, alongside prescribed home care and sustained light protection.
A single peel may improve the appearance of pigment for some people, but melasma can recur or fluctuate. It is generally managed as a long-term tendency rather than a condition with a guaranteed permanent removal. Maintenance, reduced light exposure and review of the skincare plan may remain important after initial improvement.
The home phase may include clinician-selected topical products, gentle cleansing, moisturising and avoiding unapproved exfoliants or irritating products. Instructions vary between protocols. The key point is consistency and reporting significant discomfort promptly, rather than increasing frequency or adding extra active ingredients without advice.
Visible light can contribute to pigmentation in many people with melasma, alongside ultraviolet radiation. This is why a clinician may discuss broad-spectrum sunscreen, shade, hats and, in some cases, tinted protection. The most suitable measures depend on the person, their skin and their daily exposure.
It may be sensible to delay if a holiday will involve substantial direct sun, heat or difficulty following aftercare. Freshly treated skin can be more reactive, and high exposure can undermine pigment control. Discuss travel dates at consultation so that timing can be considered before any preparation begins.
Do not try to push through marked burning, swelling, blistering, weeping or increasing pain. Stop unapproved active products and contact the clinician responsible for the protocol promptly. These symptoms may indicate that the skin barrier is irritated and that the plan needs review or modification.
Seek medical assessment for a new, changing, irregular, raised, bleeding or crusting lesion, or where the cause of a dark patch is uncertain. Cosmetic pigmentation treatment is not appropriate until concerning lesions and other possible causes have been considered. Active rashes or broken skin also need assessment before peeling.
Tell us what you are seeing on your skin, how long it has been there and what you have already tried. You will get a considered reply setting out what the finding is likely to be, which treatments address it and which do not.
hello@aestheticlaunchlab.comPlease do not send clinical photographs or medical records by email. If something has gone wrong after a treatment, contact the practitioner who treated you, or NHS 111, rather than waiting for a reply here.